Phenotype analysis impacts testing strategy in patients with Currarino syndrome

G. Cuturilo, J. C. Hodge, C. K. Runke, Erik C Thorland, M. A. Al-Owain, J. W. Ellison, Dusica Babovic-Vuksanovic

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Currarino syndrome (OMIM 175450) presents with sacral, anorectal, and intraspinal anomalies and presacral meningocele or teratoma. Autosomal dominant loss-of-function mutations in the MNX1 gene cause nearly all familial and 30% of sporadic cases. Less frequently, a complex phenotype of Currarino syndrome can be caused by microdeletions of 7q containing MNX1. Here, we report one familial and three sporadic cases of Currarino syndrome. To determine the most efficient genetic testing approach for these patients, we have compared results from MNX1 sequencing, chromosomal microarray, and performed a literature search with analysis of genotype-phenotype correlation. Based on the relationship between the type of mutation (intragenic MNX1 mutations vs 7q microdeletion) and the presence of intellectual disability, growth retardation, facial dysmorphism, and associated malformations, we propose a testing algorithm. Patients with the classic Currarino triad of malformations but normal growth, intellect, and facial appearance should have MNX1 sequencing first, and only in the event of a normal result should the clinician proceed with chromosomal microarray testing. In contrast, if growth delay and/or facial dysmorphy and/or intellectual disability are present, chromosomal microarray should be the first method of choice for genetic testing.

Original languageEnglish (US)
JournalClinical Genetics
DOIs
StateAccepted/In press - 2015

Fingerprint

Phenotype
Genetic Testing
Intellectual Disability
Mutation
Growth
Meningocele
Genetic Databases
Teratoma
Genetic Association Studies
Currarino triad
Genes
Anorectal Malformations

Keywords

  • Chromosomal microarray
  • Currarino syndrome
  • Distal 7q deletions
  • MNX1 gene
  • Sequencing
  • Testing algorithm

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Phenotype analysis impacts testing strategy in patients with Currarino syndrome. / Cuturilo, G.; Hodge, J. C.; Runke, C. K.; Thorland, Erik C; Al-Owain, M. A.; Ellison, J. W.; Babovic-Vuksanovic, Dusica.

In: Clinical Genetics, 2015.

Research output: Contribution to journalArticle

@article{f13cf7dd051f42fd808e3be1a7239cca,
title = "Phenotype analysis impacts testing strategy in patients with Currarino syndrome",
abstract = "Currarino syndrome (OMIM 175450) presents with sacral, anorectal, and intraspinal anomalies and presacral meningocele or teratoma. Autosomal dominant loss-of-function mutations in the MNX1 gene cause nearly all familial and 30{\%} of sporadic cases. Less frequently, a complex phenotype of Currarino syndrome can be caused by microdeletions of 7q containing MNX1. Here, we report one familial and three sporadic cases of Currarino syndrome. To determine the most efficient genetic testing approach for these patients, we have compared results from MNX1 sequencing, chromosomal microarray, and performed a literature search with analysis of genotype-phenotype correlation. Based on the relationship between the type of mutation (intragenic MNX1 mutations vs 7q microdeletion) and the presence of intellectual disability, growth retardation, facial dysmorphism, and associated malformations, we propose a testing algorithm. Patients with the classic Currarino triad of malformations but normal growth, intellect, and facial appearance should have MNX1 sequencing first, and only in the event of a normal result should the clinician proceed with chromosomal microarray testing. In contrast, if growth delay and/or facial dysmorphy and/or intellectual disability are present, chromosomal microarray should be the first method of choice for genetic testing.",
keywords = "Chromosomal microarray, Currarino syndrome, Distal 7q deletions, MNX1 gene, Sequencing, Testing algorithm",
author = "G. Cuturilo and Hodge, {J. C.} and Runke, {C. K.} and Thorland, {Erik C} and Al-Owain, {M. A.} and Ellison, {J. W.} and Dusica Babovic-Vuksanovic",
year = "2015",
doi = "10.1111/cge.12572",
language = "English (US)",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Phenotype analysis impacts testing strategy in patients with Currarino syndrome

AU - Cuturilo, G.

AU - Hodge, J. C.

AU - Runke, C. K.

AU - Thorland, Erik C

AU - Al-Owain, M. A.

AU - Ellison, J. W.

AU - Babovic-Vuksanovic, Dusica

PY - 2015

Y1 - 2015

N2 - Currarino syndrome (OMIM 175450) presents with sacral, anorectal, and intraspinal anomalies and presacral meningocele or teratoma. Autosomal dominant loss-of-function mutations in the MNX1 gene cause nearly all familial and 30% of sporadic cases. Less frequently, a complex phenotype of Currarino syndrome can be caused by microdeletions of 7q containing MNX1. Here, we report one familial and three sporadic cases of Currarino syndrome. To determine the most efficient genetic testing approach for these patients, we have compared results from MNX1 sequencing, chromosomal microarray, and performed a literature search with analysis of genotype-phenotype correlation. Based on the relationship between the type of mutation (intragenic MNX1 mutations vs 7q microdeletion) and the presence of intellectual disability, growth retardation, facial dysmorphism, and associated malformations, we propose a testing algorithm. Patients with the classic Currarino triad of malformations but normal growth, intellect, and facial appearance should have MNX1 sequencing first, and only in the event of a normal result should the clinician proceed with chromosomal microarray testing. In contrast, if growth delay and/or facial dysmorphy and/or intellectual disability are present, chromosomal microarray should be the first method of choice for genetic testing.

AB - Currarino syndrome (OMIM 175450) presents with sacral, anorectal, and intraspinal anomalies and presacral meningocele or teratoma. Autosomal dominant loss-of-function mutations in the MNX1 gene cause nearly all familial and 30% of sporadic cases. Less frequently, a complex phenotype of Currarino syndrome can be caused by microdeletions of 7q containing MNX1. Here, we report one familial and three sporadic cases of Currarino syndrome. To determine the most efficient genetic testing approach for these patients, we have compared results from MNX1 sequencing, chromosomal microarray, and performed a literature search with analysis of genotype-phenotype correlation. Based on the relationship between the type of mutation (intragenic MNX1 mutations vs 7q microdeletion) and the presence of intellectual disability, growth retardation, facial dysmorphism, and associated malformations, we propose a testing algorithm. Patients with the classic Currarino triad of malformations but normal growth, intellect, and facial appearance should have MNX1 sequencing first, and only in the event of a normal result should the clinician proceed with chromosomal microarray testing. In contrast, if growth delay and/or facial dysmorphy and/or intellectual disability are present, chromosomal microarray should be the first method of choice for genetic testing.

KW - Chromosomal microarray

KW - Currarino syndrome

KW - Distal 7q deletions

KW - MNX1 gene

KW - Sequencing

KW - Testing algorithm

UR - http://www.scopus.com/inward/record.url?scp=84924777839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924777839&partnerID=8YFLogxK

U2 - 10.1111/cge.12572

DO - 10.1111/cge.12572

M3 - Article

C2 - 25691298

AN - SCOPUS:84955208060

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

ER -